The First Universal Kidney Transplant: Medical Breakthrough in Organ Compatibility
Over 100,000 people wait for organ transplants in America alone. Thousands die each year because a compatible organ never arrives. Blood type incompatibility has been an immutable barrier since the dawn of transplantation—until now.
In October 2023, surgeons in China accomplished what seemed impossible: they transplanted a Type A kidney into a Type O recipient. The organ functioned normally. No rejection occurred. The secret? Bacterial enzymes that stripped away incompatible blood markers, converting the kidney into a universal donor organ during a two-hour perfusion treatment.
This book takes you inside that groundbreaking procedure and explores what it means for medicine's future. You'll discover how researchers found these remarkable enzymes in human gut bacteria, how they convinced the medical establishment that permanently altering organs was feasible, and why a brain-dead recipient provided the ethical pathway for testing this radical intervention in humans.
But this is not a simple success story. Three days after transplant, the converted antigens began regenerating. Immune responses emerged. The questions multiplying from this first case are as significant as the achievement itself: Can enzyme treatment prevent long-term rejection? Will recipients need ongoing interventions to maintain compatibility? How do we scale this technology when millions need transplants?
You'll learn why Type O patients wait years longer than others for kidneys, how current allocation systems waste thousands of viable organs annually, and why removing blood type barriers could save healthcare systems billions while transforming countless lives. The book examines the scientific challenges still confronting researchers, from incomplete antigen removal to the complexities of treating different organ types.
Beyond transplantation, this breakthrough validates a larger principle: that we can modify human biology at the molecular level to solve previously intractable medical problems. The implications stretch from cancer treatment to xenotransplantation, from tissue engineering to genetic medicine.
Written for readers who want substance without jargon, this comprehensive analysis covers fifteen critical dimensions of universal organ technology—the immunology, the economics, the ethics, the global health implications, and the realistic timeline for clinical application. Whether you're a medical professional, policymaker, patient advocate, or simply someone fascinated by how science pushes boundaries, this book reveals how enzyme engineering might rewrite the rules of transplantation and what obstacles remain before that promise becomes reality.
The age of universal donor organs has begun. The question is no longer whether we can convert blood types, but whether we can do it safely, sustainably, and equitably for everyone who needs a second chance at life.
"synopsis" may belong to another edition of this title.
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New. Seller Inventory # 51877803-n
Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.
Paperback. Condition: new. Paperback. The First Universal Kidney Transplant: Medical Breakthrough in Organ Compatibility Over 100,000 people wait for organ transplants in America alone. Thousands die each year because a compatible organ never arrives. Blood type incompatibility has been an immutable barrier since the dawn of transplantation-until now. In October 2023, surgeons in China accomplished what seemed impossible: they transplanted a Type A kidney into a Type O recipient. The organ functioned normally. No rejection occurred. The secret? Bacterial enzymes that stripped away incompatible blood markers, converting the kidney into a universal donor organ during a two-hour perfusion treatment. This book takes you inside that groundbreaking procedure and explores what it means for medicine's future. You'll discover how researchers found these remarkable enzymes in human gut bacteria, how they convinced the medical establishment that permanently altering organs was feasible, and why a brain-dead recipient provided the ethical pathway for testing this radical intervention in humans. But this is not a simple success story. Three days after transplant, the converted antigens began regenerating. Immune responses emerged. The questions multiplying from this first case are as significant as the achievement itself: Can enzyme treatment prevent long-term rejection? Will recipients need ongoing interventions to maintain compatibility? How do we scale this technology when millions need transplants? You'll learn why Type O patients wait years longer than others for kidneys, how current allocation systems waste thousands of viable organs annually, and why removing blood type barriers could save healthcare systems billions while transforming countless lives. The book examines the scientific challenges still confronting researchers, from incomplete antigen removal to the complexities of treating different organ types. Beyond transplantation, this breakthrough validates a larger principle: that we can modify human biology at the molecular level to solve previously intractable medical problems. The implications stretch from cancer treatment to xenotransplantation, from tissue engineering to genetic medicine. Written for readers who want substance without jargon, this comprehensive analysis covers fifteen critical dimensions of universal organ technology-the immunology, the economics, the ethics, the global health implications, and the realistic timeline for clinical application. Whether you're a medical professional, policymaker, patient advocate, or simply someone fascinated by how science pushes boundaries, this book reveals how enzyme engineering might rewrite the rules of transplantation and what obstacles remain before that promise becomes reality. The age of universal donor organs has begun. The question is no longer whether we can convert blood types, but whether we can do it safely, sustainably, and equitably for everyone who needs a second chance at life. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Seller Inventory # 9798271499067
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9798271499067
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition. Seller Inventory # 51877803
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9798271499067
Quantity: Over 20 available
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New. Seller Inventory # 51877803-n
Quantity: Over 20 available
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: As New. Unread book in perfect condition. Seller Inventory # 51877803
Quantity: Over 20 available
Seller: CitiRetail, Stevenage, United Kingdom
Paperback. Condition: new. Paperback. The First Universal Kidney Transplant: Medical Breakthrough in Organ Compatibility Over 100,000 people wait for organ transplants in America alone. Thousands die each year because a compatible organ never arrives. Blood type incompatibility has been an immutable barrier since the dawn of transplantation-until now. In October 2023, surgeons in China accomplished what seemed impossible: they transplanted a Type A kidney into a Type O recipient. The organ functioned normally. No rejection occurred. The secret? Bacterial enzymes that stripped away incompatible blood markers, converting the kidney into a universal donor organ during a two-hour perfusion treatment. This book takes you inside that groundbreaking procedure and explores what it means for medicine's future. You'll discover how researchers found these remarkable enzymes in human gut bacteria, how they convinced the medical establishment that permanently altering organs was feasible, and why a brain-dead recipient provided the ethical pathway for testing this radical intervention in humans. But this is not a simple success story. Three days after transplant, the converted antigens began regenerating. Immune responses emerged. The questions multiplying from this first case are as significant as the achievement itself: Can enzyme treatment prevent long-term rejection? Will recipients need ongoing interventions to maintain compatibility? How do we scale this technology when millions need transplants? You'll learn why Type O patients wait years longer than others for kidneys, how current allocation systems waste thousands of viable organs annually, and why removing blood type barriers could save healthcare systems billions while transforming countless lives. The book examines the scientific challenges still confronting researchers, from incomplete antigen removal to the complexities of treating different organ types. Beyond transplantation, this breakthrough validates a larger principle: that we can modify human biology at the molecular level to solve previously intractable medical problems. The implications stretch from cancer treatment to xenotransplantation, from tissue engineering to genetic medicine. Written for readers who want substance without jargon, this comprehensive analysis covers fifteen critical dimensions of universal organ technology-the immunology, the economics, the ethics, the global health implications, and the realistic timeline for clinical application. Whether you're a medical professional, policymaker, patient advocate, or simply someone fascinated by how science pushes boundaries, this book reveals how enzyme engineering might rewrite the rules of transplantation and what obstacles remain before that promise becomes reality. The age of universal donor organs has begun. The question is no longer whether we can convert blood types, but whether we can do it safely, sustainably, and equitably for everyone who needs a second chance at life. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Seller Inventory # 9798271499067
Quantity: 1 available